Worldwide increase in patients of osteoarthritis is becoming a major health concern. It has high morbidity thus a major burden on world economy. We did this study to see the efficacy of oral etidronate on pain of osteoarthritis in postmenopausal women. We selected 64 patients with primary osteoarthritis of knee joint and randomly allocated in two groups, in-group 1 and in group 2. In group 1 we administered calcium as calcium gluconate 1.2 grams and vitamin D 800 units daily and in group 2 administered etidronate 400 mg once daily orally two hours before breakfast with 6.8 oz of water + Calcium and vitamin D. Subject with any other disease-requiring concomitant treatment or drug therapy that might affect bone and joint metabolism like thiazides diuretics, steroids previous bisphosphonates, HRT treatment, neoplasm, endocrinopathies, were excluded. Subjects were recruited and evaluated 4 weeks before the start of study. An informed consent was obtained.Base line investigations were done to exclude other bone diseases. Patients were randomly allocated to one of the two groups after run in period of four weeks and started with treatment allocated to her group. Patients were re-evaluated, 4.8, and 12 weeks after the treatment. Patients who receive etidronate treatment showed a statistically significant improvement in symptoms of pain as compared to those who received calcium and vitamin D alone. Osteoarthritis was diagnosed according to alt man`s criteria which is as follows: 1. Knee pain for most of the days of prior month. 2- Crepitus on active joint movement. 3. Morning stiffness of nee38. 5. Crepitus, bone enlargement of the knee. 6. No crepitus, bone enlargement. Osteoarthritis presents 1,2,3,4 or 1,2,3,4,5 or 1,6 Ref. No. 1: Altman`s Criteria Altman`s DATA ANALYSIS Analysis of data was carried out with the help of statistical package for social sciences (SPSS). Independent t test was used to see the differences b/w the control group and the treatment group.